GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Short Percentage of Float

Covalon Technologies (TSXV:COV) Short Percentage of Float


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Covalon Technologies's Short Percentage of Float

For the Biotechnology subindustry, Covalon Technologies's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Covalon Technologies's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Short Percentage of Float falls into.


;
;

Covalon Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Short Percentage of Float
Comparable Companies
XCNQ:ONCO TSXV:MIR TSX:SVA TSX:ONC TSXV:NRX TSXV:SHRX TSX:MBX XCNQ:DTC XCNQ:GLAB TSX:MDNA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CVALF:USA
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Website
https://www.covalon.com
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.
Executives
Amir Boloor Director
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies Headlines

No Headlines